Related Experiment Video
Updated: Sep 24, 2025
10:16
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
7.9K
Cardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review
Choon-Soo Lee1,2, Joonoh Kim1,2, Hyun-Jai Cho3
1Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Korean Circulation Journal
|May 3, 2022
Summary
Human pluripotent stem cells (hPSCs) offer promising avenues for cardiac regeneration, generating cardiomyocytes (CMCs) for treating heart failure. Direct reprogramming bypasses intermediate stages, advancing regenerative medicine for cardiovascular disease.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality, with heart failure posing a significant challenge.
- Despite advancements in pharmacological and surgical treatments, a substantial percentage of patients develop end-stage heart failure requiring transplantation.
- Human pluripotent stem cells (hPSCs) have emerged as a key focus for developing novel therapeutic strategies.
Purpose of the Study:
- To review the role of hPSCs in cardiac regeneration and the therapeutic potential of derived cardiomyocytes (CMCs).
- To discuss the clinical applications and advancements in hPSC-derived CMC therapies.
- To highlight the significance of direct somatic cell reprogramming into CMCs for regenerative medicine.
Main Methods:
- Review of existing literature on hPSC differentiation protocols for CMCs.
- Analysis of studies investigating the therapeutic effects and mechanisms of hPSC-derived CMCs in cardiac repair.
- Examination of recent progress in direct reprogramming of somatic cells into CMCs, bypassing intermediate stages.
Main Results:
- Established protocols enable the generation of cardiomyocytes (CMCs) from human pluripotent stem cells (hPSCs) for clinical applications.
- Studies demonstrate therapeutic effects of hPSCs in animal models, elucidating cardiac regeneration mechanisms.
- Biomedical engineering enhances the in vivo therapeutic potential of hPSC-derived CMCs.
- Direct reprogramming offers a pathway to mature CMCs from somatic cells, circumventing cellular reprogramming intermediates.
Conclusions:
- hPSCs and their derived CMCs hold significant promise for treating cardiovascular disease and heart failure.
- Direct reprogramming of somatic cells presents a novel and efficient approach in cardiac regenerative medicine.
- Further research and technological integration are crucial for translating these stem cell-based therapies into widespread clinical practice.
More Related Videos
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
7.5K
08:03Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
1.7K
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
01:17Stem Cell Culture
5.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.5K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:23Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K
01:13Induced Pluripotent Stem Cells
24.5K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.5K
01:29Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K